During a live event, Richard F. Riedel, MD, discussed key efficacy and safety outcomes from the phase 3 DeFi trial in patients with progressing desmoid tumors. This was a randomized phase 3 study for ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

In a smile-filled video shared to Instagram April 23, the 43-year-old reality star shared that her brain tumors have "significantly shrunk" — a milestone she says is a positive sign that ...

During a live event, Mark J. Fesler, MD, and participants discuss next steps for a 68-year-old patient with intermediate-risk myelofibrosis. In your experience with myelofibrosis, which ...

NFI causes tumours to develop on the covering of nerve cells, leading to disfigurement and other debilitating complications like pain, motor dysfunction, and malignant peripheral nerve sheath cancers.

Jazz Pharmaceuticals and Zymeworks, Inc. have announced that Jazz and Zymeworks BC, Inc. (a Zymeworks subsidiary) have entered into a licensing agreement, under which Jazz is to acquire the ...

Abdominal reconstruction in the contaminated or potentially-contaminated abdomen is challenging because of the high risk of re-infection and hernia recurrence. Surgical techniques, synthetic ...